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Introduction: If sympathetic hyperactivity seems to be associated to
several components of the metabolic syndrome, its involvement in the deve-
lopment of metabolic syndrome has not been clearly defined.
Aim: It was to determine if a chronic increase of the sympathetic nervous
activity is a sufficient condition for the development of metabolic disorders. For
that purpose, we used a transgenic mouse model, in which the gene coding for
the reuptake norepinephrine transporter (NET) has been deleted; these animals
display increased plasma catecholamine rates, associated to slight increases in
blood pressure and heart rate. We focused on the consequences of this sympa-
thetic hyperactivity on glucose and lipid metabolism in this mouse model.
Methods: Heterozygous NET knockout mice (+/-) or wild-type mice (+/+)
were fed either with a normal chow or a 30% w/v fructose in drinking water
during a period of 15 weeks to induce metabolic disorders. Metabolic para-
meters (plasma triglycerides and total cholesterol, intraperitoneal glucose
tolerance test, IPGTT) were measured after a 4h fasting period before treat-
ment and then repeated every 5 weeks.
Results: No significant difference on triglycerides or cholesterol rates
could be detected after the 15 weeks period. Heterozygous mice displayed
clear glucose intolerance already before starting the fructose diet (area under
the curve (%)=25434 vs 20822, p=0.013 for +/- and +/+ mice respectively).
These animals were also much more sensitive to high fructose, since a 50%
increase in the area under the curve of the IPGTT was obtained at the end of
the high fructose diet, compared to the 11% increase in +/+ mice.
Conclusion: Our data suggest that constitutive chronic sympathetic hyper-
activity can induce the early development of carbohydrate metabolism disor-
ders. Moreover, it seems to represent a major factor of susceptibility to diet-
induced metabolic dysfunction.
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Introduction: Determination of adipose tissue proportion, as well as its
spatial distribution, is a major part of metabolic syndrome assessment. Various
methods, commonly used in mouse models, are either indirect measurement,
invasive (destructive) or imaging techniques. Indirect measurement tech-
niques, such as deuterium dilution (considered as gold standard) or bioim-
pedance are based on the measurement of body composition. They give access
to the measure of total body fat, without distinction between visceral and sub-
cutaneous fat volumes. Sacrifice and ex-vivo tissue weight allow both total fat
measurement and partition between subcutaneous and visceral fat pad. It is a
direct method that does not allow for longitudinal studies. Non-invasive
micro-imaging modalities (magnetic resonance imaging and μCT) add, over
others, the advantage of spatial localization of fat, in vivo.
Aim: Of our study was to compare results of measurements of total body
fat done by μCT and bioimpedance in mice.
Methods: μCT was done using a dedicated in vivo imaging instrument
(eXplore Vision 120, GE, USA) on 30 anesthetized mice. Each acquisition
lasted approximately 12 min. Just after μCT, measurement of body composi-
tion was performed by bioimpedance (ImpediVET, ImpediMed, USA).
Results: The average value of total body fat by μCT is 5% higher than that
obtained by bioimpedance. The standard deviation calculated from μCT mea-
surements is lower than that obtained with bioimpedance (4.8% vs 6.8%
respectively). The linear correlation of μCT and bioimpedance measure of
total adipose tissue is moderate (r² = 0.55). 
Conclusion: It is the first time, to our knowledge, that a comparison of
total fat volume measurement between μCT and bioimpedance is performed in
mice. Surprisingly, the correlation appears not to be so trivial between the
2 methods. Before a deeper exploration, comparison of results obtained with
these 2 methods should be made with caution.
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Background: Psoriasis is a chronic inflammatory disease associated with
multiple comorbidities that are components of the metabolic syndrome (MS).
Several studies have objectified a high prevalence of MS in psoriasis patients.
Objective: To determine the prevalence of MS and its components in pso-
riasis patients compared with controls, also the factors determinants the occur-
rence of MS in our patients.
Patients and Methods: This was a prospective study including 100 psori-
asis patients versus 100 controls seen in consultation or in hospitals.
Conducted for a period of 12 months.
Results: The prevalence of MS was higher in patients with psoriasis
compared with controls (OR=2.89, p=0,0002). With a significant increase in
obesity (OR=3.25, p=0.001), hypertriglyceridemia (OR=3.9, p=0.013) and
glucose intolerance (OR = 2.13, p = 0.046). Risk factors determining the
appearance of SM in psoriatic were age, family history of psoriasis, seniority
of psoriasis, but we did not find a correlation with sex, severity of psoriasis
and the clinical form.
Conclusion: The management of psoriasis will integrate research risk fac-
tors for a possible metabolic syndrome and its treatment through a multidisci-
plinary approach.
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Metabolic Syndrome (MetS) is a cluster of metabolic risk factors,
including visceral obesity and insulin resistance (IR), associated with a higher
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